Category Added in a WPeMatico Campaign
US Business
Regeneron’s Antibody Drug Cuts Risk of Death in Some Covid-19 Patients
Trial results for REGEN-COV buoy hopes that doctors could soon have a new way to tackle severe hospital cases.
